Innovation1 Biotech Financials
| IVBT Stock | USD 0 0.00 0.00% |
With this module, you can analyze Innovation1 financials for your investing period. You should be able to track the changes in Innovation1 Biotech individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Innovation1 |
Understanding current and past Innovation1 Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Innovation1 Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Innovation1 Biotech's assets may result in an increase in income on the income statement.
The data published in Innovation1 Biotech's official financial statements typically reflect Innovation1 Biotech's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Innovation1 Biotech's quantitative information. For example, before you start analyzing numbers published by Innovation1 accountants, it's essential to understand Innovation1 Biotech's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Please note, the imprecision that can be found in Innovation1 Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Innovation1 Biotech. Check Innovation1 Biotech's Beneish M Score to see the likelihood of Innovation1 Biotech's management manipulating its earnings.
Innovation1 Biotech Stock Summary
Innovation1 Biotech competes with Sino Biopharmaceutica, Defence Therapeutics, Enlivex Therapeutics, and Achilles Therapeutics. Innovation1 Biotech Inc. operates as a small molecule drug discovery company. The company was founded in 2014 and is based in New York, New York. Innovation1 Biotech operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| Business Address | 40 Wall Street, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.innovation1bio.com |
| Phone | 646 380 1923 |
| Currency | USD - US Dollar |
Innovation1 Biotech Key Financial Ratios
Innovation1 Biotech's financial ratios allow both analysts and investors to convert raw data from Innovation1 Biotech's financial statements into concise, actionable information that can be used to evaluate the performance of Innovation1 Biotech over time and compare it to other companies across industries.| Return On Equity | -1.79 | |||
| Return On Asset | -0.0781 | |||
| Beta | 5.08 | |||
| Z Score | 4.8 |
Innovation1 Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Innovation1 Biotech's current stock value. Our valuation model uses many indicators to compare Innovation1 Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Innovation1 Biotech competition to find correlations between indicators driving Innovation1 Biotech's intrinsic value. More Info.Innovation1 Biotech is rated fifth overall in return on equity category among its peers. It is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Innovation1 Biotech's earnings, one of the primary drivers of an investment's value.Innovation1 Biotech Systematic Risk
Innovation1 Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Innovation1 Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Innovation1 Biotech correlated with the market. If Beta is less than 0 Innovation1 Biotech generally moves in the opposite direction as compared to the market. If Innovation1 Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Innovation1 Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Innovation1 Biotech is generally in the same direction as the market. If Beta > 1 Innovation1 Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Additional Tools for Innovation1 OTC Stock Analysis
When running Innovation1 Biotech's price analysis, check to measure Innovation1 Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation1 Biotech is operating at the current time. Most of Innovation1 Biotech's value examination focuses on studying past and present price action to predict the probability of Innovation1 Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation1 Biotech's price. Additionally, you may evaluate how the addition of Innovation1 Biotech to your portfolios can decrease your overall portfolio volatility.